The official, Dr. George F. Tidmarsh, a top regulator at the agency, said disagreements over a new program to rapidly approve medications had caused tensions with agency officials.
F.D.A. Drug Unit Chief Is Placed on Leave, and Cites a ‘Toxic’ Environment
